Skip to main content
. 2020 Jun 16;17(12):4305. doi: 10.3390/ijerph17124305

Table 3.

Median times for the main outcomes.

Time-to-Outcome Intervals Total Sample Stratified for Sex Stratified for Age
Males Females Age <55 Years Age ≥55 Years
n at Day 0 Outcomes Censored Median (IQR) Median (IQR) Median (IQR) p-Value 1 Median (IQR) Median (IQR) p-Value 1
Date of perceived risk contact to Start of symptoms 2 39 39 0 4 (3, 7) 5 (3, 7) 4 (2, 7) 0.387 5 (3, 7) 4 (2, 5) 0.125
Start of symptoms to End of symptoms 76 55 21 14 (10, -) 13 (8, 17) 17 (11, -) 0.024 14 (10, 22) 19 (11, -) 0.129
Start of symptoms to First positive PCR 3 76 76 0 2 (1, 5) 2 (1, 4) 3 (1, 5) 0.081 2 (1, 4) 3 (1, 6) 0.784
Start of symptoms to Negative PCR 76 44 32 31 (21, -) 21 (18, -) 33 (25, -) 0.025 28 (10, 39) 33 (25, -) 0.207
First positive PCR to Negative PCR 76 44 32 25 (18, 37) 19 (16, -) 30 (22, 37) 0.076 22 (17, 37) 31 (23, -) 0.119
End of symptoms to Negative PCR 4 53 33 20 15 (9, 25) 10 (8, 16) 17 (12, 24) 0.322 13 (8, 24) 18 (14, 26) 0.522

The upper limit (p75%) of the IQR could not be obtained in some groups due to censoring. 1 p-values assess differences in the hazard ratio of each outcome across age and sex groups, obtained from the corresponding Cox regression model including age and sex as covariates. 2 For this outcome, 37 patients could not recall any risk contact. 3 We assigned a value of 0.5 days in 10 patients who reported that symptom onset and their first positive PCR result occurred on the same day. 4 Of 55 patients with a date for end of symptoms (not censored for this outcome), one had a negative PCR result 4 days before the date of end of symptoms, and another had a negative PCR result the same date as the end of symptoms; both patients were excluded from this analysis.